+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
ID06629376

Study of Safety, Tolerability, and Effects of Multiple Doses of SSS11 Injection in Adults With Gout and High Uric Acid

Led by Shenyang Sunshine Pharmaceutical Co., LTD. · Updated on 2025-05-28

60

Participants Needed

1

Research Sites

33 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, pharmacokinetics, and preliminary pharmacological effects of multiple doses of PEGylated recombinant Candida urate oxidase SSS11 in adults with gout and hyperuricemia. This phase 1 trial uses a randomized, double-blind, placebo-controlled design to gather important safety and dosing information. The study is sponsored by Shenyang Sunshine Pharmaceutical Co., LTD and aims to better understand how this investigational drug behaves in the body and its initial effects on uric acid levels. Participants will be assigned to one of several groups receiving different doses of SSS11 4 mg, 8 mg, 12 mg, 16 mg, or 20 mg or a placebo. The drug is given by intravenous infusion over at least 2 hours. The study includes a 4-week screening period, followed by a treatment period lasting either 4 or 8 weeks, and then a 4-week observation period. This setup allows researchers to compare various dose levels and monitor participants closely during and after treatment. Throughout the study, participants will undergo safety assessments for up to 12 weeks, including monitoring blood uric acid levels to evaluate changes from baseline. Researchers will measure the duration and proportion of time blood uric acid remains below 360 bc molL. The trial involves regular medical evaluations, laboratory tests, and close observation to track how well participants tolerate the injections and to collect detailed pharmacokinetic data on the investigational drug.

CONDITIONS

Brief Title

Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia

Research Team

H

hejian zou, professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here